THERAVANCE BIOPHARMA INC shareholders Q3 2023

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Y-Intercept (Hong Kong) Ltd 16,137$139,2620.01%
Arkadios Wealth Advisors 17,500$151,0250.01%
MARTINGALE ASSET MANAGEMENT L P 78,684$679,0440.01%
HRT FINANCIAL LP 139,898$1,2070.01%
ExodusPoint Capital Management, LP 117,318$1,0120.01%
TUDOR INVESTMENT CORP ET AL 107,748$929,8650.01%
D. E. Shaw & Co., Inc. 689,561$5,950,9120.01%
CANTOR FITZGERALD, L. P. 20,000$172,6000.01%
ROYCE & ASSOCIATES LP 59,009$509,2480.01%
Newbridge Financial Services Group, Inc. 1,000$8,6300.00%
Schonfeld Strategic Advisors LLC 57,426$495,5850.00%
China Universal Asset Management Co., Ltd. 1,357$120.00%
Ameritas Investment Partners, Inc. 6,083$52,4960.00%
MetLife Investment Management, LLC 33,942$292,9190.00%
MACQUARIE GROUP LTD 208,783$1,802,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 3,472$29,9630.00%
AMERICAN INTERNATIONAL GROUP, INC. 28,140$242,8480.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 52,615$8760.00%
Swiss National Bank 109,042$941,0320.00%
Mirae Asset Global Investments Co., Ltd. 44,532$384,3110.00%
External links

This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.